Clinical Trials Browser

Active not recruiting × Locally Advanced Rectal Cancer × tislelizumab × Clear all

NCT06056804 2025-04-02

Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer

Phase 2 Active not recruiting

Gastrointestinal

Locally Advanced Rectal Cancer